Clofarabine exerts antileukemic activity against cytarabine‐resistant B‐cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.

MLA

Huang, Meixian, et al. “Clofarabine Exerts Antileukemic Activity against Cytarabine‐resistant B‐cell Precursor Acute Lymphoblastic Leukemia with Low Deoxycytidine Kinase Expression.” Cancer Medicine, vol. 7, no. 4, Apr. 2018, pp. 1297–316. EBSCOhost, https://doi.org/10.1002/cam4.1323.

APA

Huang, M., Inukai, T., Miyake, K., Tanaka, Y., Kagami, K., Abe, M., Goto, H., Minegishi, M., Iwamoto, S., Sugihara, E., Watanabe, A., Somazu, S., Shinohara, T., Oshiro, H., Akahane, K., Goi, K., & Sugita, K. (2018). Clofarabine exerts antileukemic activity against cytarabine‐resistant B‐cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression. Cancer Medicine, 7(4), 1297–1316. https://doi.org/10.1002/cam4.1323

Chicago

Huang, Meixian, Takeshi Inukai, Kunio Miyake, Yoichi Tanaka, Keiko Kagami, Masako Abe, Hiroaki Goto, et al. 2018. “Clofarabine Exerts Antileukemic Activity against Cytarabine‐resistant B‐cell Precursor Acute Lymphoblastic Leukemia with Low Deoxycytidine Kinase Expression.” Cancer Medicine 7 (4): 1297–1316. doi:10.1002/cam4.1323.